FOLH1 and neoplasm: Evazalipour et al. (2014) evaluated the tumor targeting of radiolabeled PSMA Nbs in LNCaP (PSMA+)- and PC3 (PSMA−)-xenografted mice using SPECT/Micro-CT [27].